The U.S. Senate Homeland Security and Governmental Affairs Committee voted Thursday to hold Anthony Fauci in contempt of Congress [1, 2].
The move signals a deepening conflict between congressional investigators and the former public health official over the disclosure of government records and testimonies. This rare legislative action follows a hearing where the committee sought specific answers regarding past administrative decisions.
The vote occurred in Washington, D.C., after Fauci repeatedly refused to answer questions posed by committee members [1]. According to reports, Fauci invoked his Fifth Amendment right against self-incrimination more than 100 times during the proceedings [1].
Members of the committee argued that the frequent use of the Fifth Amendment obstructed the legislative body's ability to conduct oversight. The committee's decision to pursue a contempt charge is a formal mechanism used when a witness refuses to comply with a congressional subpoena, or refuses to provide testimony [3].
Fauci did not provide a public statement immediately following the vote. The committee's action now moves the matter toward potential legal referrals, though the specific next steps for enforcement remain under deliberation by Senate leadership [1, 2].
The hearing was marked by high tension as senators questioned the former official on public health protocols and government transparency. The repeated refusal to answer specific queries led the panel to conclude that the witness was willfully obstructing the inquiry [3].
“The Senate committee voted to hold Anthony Fauci in contempt of Congress”
A contempt of Congress citation is a formal expression of disapproval that can lead to criminal referrals to the Department of Justice. By invoking the Fifth Amendment over 100 times, Fauci utilized a constitutional protection that prevents forced self-incrimination, but the Senate's response indicates a low tolerance for such tactics during high-profile oversight hearings. This event underscores the ongoing political polarization surrounding public health governance and the limits of congressional subpoena power.
